Stiripentol in Dravet Syndrome
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01533506 |
Expanded Access Status :
No longer available
First Posted : February 15, 2012
Last Update Posted : February 28, 2013
|
- Study Details
- Tabular View
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Dravet Syndrome | Drug: stiripentol |
Study Type : | Expanded Access |
Official Title: | Compassionate Use of Stiripentol in Intractable Epilepsy Due to Dravet Syndrome |
Study Start Date : | February 2012 |
Estimated Primary Completion Date : | February 2013 |
Estimated Study Completion Date : | February 2013 |

- Drug: stiripentol
Stiripentol up to 30 mg/kg/day to control seizuresOther Name: Diacomit

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 11 Years and older (Child, Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Genetic diagnosis of Dravet syndrome with intractable seizures despite failing all available medications for seizures

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01533506
United States, Minnesota | |
Mayo Clinic in Rochester | |
Rochester, Minnesota, United States, 55905 |
Principal Investigator: | Elaine Wirrell, MD | Mayo Clinic |
Responsible Party: | Elaine C. Wirrell, Consultant, Mayo Clinic |
ClinicalTrials.gov Identifier: | NCT01533506 |
Other Study ID Numbers: |
12-000690 |
First Posted: | February 15, 2012 Key Record Dates |
Last Update Posted: | February 28, 2013 |
Last Verified: | February 2013 |
treatment with stiripentol |
Epilepsies, Myoclonic Syndrome Disease Pathologic Processes Epilepsy, Generalized Epilepsy |
Brain Diseases Central Nervous System Diseases Nervous System Diseases Epileptic Syndromes Stiripentol Anticonvulsants |